... Staging of small cell
and non- smallcelllung cancer. University of Iowa Virtual Hos-
pital; 1999.
6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-
ment in patients with lung cancer: ... Treatment of
Cancer Quality-of-Life Questionnaire -Lung Cancer- 17
items; EQ-5D: EuroQoL-5 Dimensions; HRQL: Health-
related Quality of Life; NSCLC: Non- SmallCellLung Can-
cer; SF-36: Short-Form ... state
utilities for metastatic breast cancer. Br J Cancer 2006,
95(6):683-90.
17. Cancer Research UK [http://www.cancerresearchuk.org
]
18. Cancer Help [http://www.cancerhelp.org.uk
]
19. Association for...
... of non- small- cell lung
cancer. Int J Radiat Oncol Biol Phys 2002, 52:382-389.
16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapy
in treatment of stage I non- smallcell ... early-
stage non- small- celllung cancer: clinical implications. Radiother Oncol
2010, 94:1-11.
27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic body
radiotherapy for T1-3N0 non- small ... Bosch W, Lockett MA, Perez CA:
Clinical dose-volume histogram analysis for pneumonitis after 3D
treatment for non- smallcelllungcancer (NSCLC). Int J Radiat Oncol Biol
Phys 1999, 45:323-329.
25....
... surgery in patients with
operable lung cancer.
A randomized phase III trial of Radiosurgery Or Surgery
for operable Early stage (stage 1A) non- smallcell Lung
cancer (ROSEL, ClinicalTrials.gov ... body radiotherapy forstage I
non- smallcelllung cancer. Radiother Oncol 2007, 85:429-434.
39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-
eral primary lung cancers: the Indiana ... Lagerwaard FJ:
Critical review of nonsurgical treatment options forstage I
non- smallcelllung cancer. Oncologist 2008, 13:309-319.
41. Brock J, Ashley S, Bedford J, Nioutsikou E, Partridge M,...
... as lung cancer. It is more convenient for the patients and reduces health care costs.
This study reports our results on patients with medically inoperable, early stage, non- smallcell lung
cancer ... not for citation purposes)
Radiation Oncology
Open Access
Research
Absence of toxicity with hypofractionated 3-dimensional radiation
therapy for inoperable, early stage non- smallcelllung cancer
Sergio ... 6
(page number not for citation purposes)
Background
The use of accelerated hypofractionated radiation therapy
is an attractive option for patients with early stage non-
small celllungcancer (NSCLC)...
... Estimating the world cancer
burden: Globocan 2000. Int J Cancer 2001, 94:153-156.
2. Non- smallCellLungCancer Collaborative Group: Chemotherapy
in nonsmallcelllung cancer: a meta-analysis ... cisplatin-teniposide in patients with
advanced non- small- celllung cancer. The European Organi-
zation for Research and Treatment of CancerLung Cancer
Cooperative Group. J Clin Oncol 1998, 16:2133-2141.
7. ... paclitaxel plus gemcitabine in advanced non- small-
cell lung cancer: a phase III trial of the European Organiza-
tion for Research and Treatment of CancerLung Cancer
Group – EORTC 08975. J Clin Oncol...
... Non- small- celllungcancer harbouring mutations in the EGFR
kinase domain. Clin Transl Oncol 2010, 12:75-80.
9. Gazdar AF: Activating and resistance mutations of EGFR in non- small- cell
lung cancer: ... lungcancer patients.
Methods: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non- small- cell
lungcancer (NSCLC) cell lines and tumor samples from 78 stage ... antibodies for the detection of
EGFR mutations in non- small- celllung cancer. Clin Cancer Res 2009,
15:3023-3028.
13. Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL,
Travis WD: Lung...
... iotherapy, Oligometastases, Non- SmallCellLung Cancer
Background
Non- smallcelllungcancer (NSCLC) is the leading
cause of cancer mortality in the United States [1].
Patients with stage IV NSCLC typically ... of 7
RESEARC H Open Access
Comparison of outcomes in patients with stage III
versus limited stage IV non- smallcelllung cancer
Praveena Cheruvu
1
, Su K Metcalfe
1
, Justin Metcalfe
1
, Yuhchyau ... Paul Okunieff
2
and Michael T Milano
1*
Abstract
Background: Standard therapy for metastatic nonsmallcelllungcancer (NSCLC) includes palliative systemic
chemotherapy and/or radiotherapy....
...
Abstract
Background: To evaluate the performance of surface-based deformable image registration (DR)
for adaptive radiotherapy of non- smallcelllungcancer (NSCLC).
Methods: Based on 13 patients ... megavoltage CT imaging during exter-
nal beam radiotherapy for non- small- celllung cancer: obser-
vations on tumor regression during treatment. Int J Radiat
Oncol Biol Phys 2005, 63:1024-1028.
10. ... of deformable image registration
Comparison of CT
plan
and CT
deform
was performed for
evaluation of the DR. Based on ROI
extended
, DR improved
the CC for images acquired mid-way of the treatment
course...
... irradiation
for medically inoperable patients with peripheral stage I
non- smallcelllung cancer. LungCancer 1999, 26:137-142.
23. Slotman BJ, Antonisse IE, Njo KH: Limited field irradiation in
early stage ... 1 of 9
(page number not for citation purposes)
Radiation Oncology
Open Access
Research
Stereotactic, single-dose irradiation of stage I non- smallcelllung
cancer and lung metastases
Peter Fritz*
1
, ... radiotherapy
for stage I non- smallcelllungcancer using a novel irradiation
technique: patient self-controlled breath-hold and beam
switching using a combination of linear accelerator and CT
scanner. Lung...
... marker expression in tumor cells versus stromal cells in non
smallcelllung cancer. Clin Cancer Res 2007, 13:6649-57.
24. World Health Organization: Histological Typing of Lung and Pleural
Tumours. ... Paclitaxel-carboplatin alone or with
bevacizumab for non- small- celllung cancer. N Engl J Med 2006,
355:2542-50.
21. Besse B, Ropert S, Soria JC: Targeted therapies in lung cancer. Ann Oncol
2007, 18(Suppl 9):ix135-ix142.
22. ... in
non- smallcelllung cancer. Clin Cancer Res 2008, 14:5220-7.
30. Andersen S, Eilertsen M, Donnem T, et al: Diverging prognostic impacts of
hypoxic markers according to NSCLC histology. Lung Cancer...
... non- smallcelllungcancer
cell lines. Mol Cancer Res. 2006; 4(8): 521-8.
102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to
classify non- small- celllungcancer patients for ... death world-
wide (1). Lungcancer is generally classified into two
histological types, smallcelllungcancer (SCLC) and
non smallcelllungcancer (NSCLC).
NSCLC accounts
for approximately 85% ... advanced non- small- celllung cancer. Results
of a meta-analysis of the literature. Chest. 1994; 106(3): 861-5.
8. Grilli R, Oxman AD, Julian JA. Chemotherapy for advanced
non- small- celllung cancer: ...
... Napoli
1
, Giacomo Carteni’
1
Abstract
Background: Defining the optimal treatmentfor patients with inoperable nonsmallcelllungcancer (NSCLC),
presenting with metastatic mediastinal lymph nodes, ... after the first few cycles should not
automatically discourage to continue treatment.
Introduction
In non- smallcelllungcancer (NSCLC), mediastinal
lymphnode involvement comprises a wide spectrum ... induced by
first-line chemotherapy with single agent
docetaxel in a patient with advanced non small
celllung cancer
Ferdinando Riccardi
1*
, Giuseppe Di Lorenzo
1
, Carlo Buonerba
1
, Guglielmo Monaco
2
,...
... JD, Komaki R, Mohan R:
Dose and volume reduction for normal lung using intensity-
modulated radiotherapy for advanced -stage non- small- celllung
cancer. Int J Radiat Oncol Biol Phys 2004, 58:1258-1267.
21. ... W, Lockett MA, Perez CA:
Clinical dose-volume histogram analysis for pneumonitis after 3D
treatment for non- smallcelllungcancer (NSCLC). Int J Radiat Oncol Biol
Phys 1999, 45:323-329.
15. ... method for
the management of unresectable locally advanced non-
small celllungcancer (NSCLC). Unfortunately, the longer
survival is achieved at the price of greater toxicity of the
lung and...
... energy agency (IAEA)
consultants' meeting on elective nodal irradiation in lung
cancer: non- smallcelllungcancer (NSCLC). Int J Radiat Oncol
Biol Phys 2008, 72(2):335-342.
6. Therasse P, ... response to
treatment in solid tumors. European Organization for
Research and Treatment of Cancer, National Cancer Insti-
tute of the United States, National Cancer Institute of Can-
ada. J Natl Cancer ... Sahijdak WM, Hayman JA: Incidental dose to clinically
negative nodes from conformal treatment fields for nons-
mall celllung cancer. Int J Radiat Oncol Biol Phys 1999, 45:S244.
13. Klopp AH, Chang...